King Chulalongkorn Memorial Hospital is a public general and tertiary referral hospital in Bangkok, Thailand. It is operated by the Thai Red Cross Society, and serves as the teaching hospital for the Faculty of Medicine, Chulalongkorn University and Srisavarindhira Thai Red Cross Institute of Nursing.

There are 1,435 beds in King Chulalongkorn Memorial Hospital.

During the past decade, King Chulalongkorn Memorial Hospital conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 23 clinical trials were completed, i.e. on average, 26.4% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 14 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Chulalongkorn Memorial Hospital" #1 sponsor was "Chulalongkorn University" with 22 trials, followed by "King Chulalongkorn Memorial Hospital" with 9 trials sponsored, "Boehringer Ingelheim" with 8 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Chulalongkorn Memorial Hospital" #1 collaborator was "King Chulalongkorn Memorial Hospital" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 2 trials as a collaborator and "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 106 trials.

According to Clinical.Site data, the most researched conditions in "King Chulalongkorn Memorial Hospital" are "Hepatitis B, Chronic" (5 trials), "HIV Infections" (4 trials), "Cervical Cancer" (3 trials), "Coronary Artery Disease" (3 trials) and "Advanced Solid Tumors" (2 trials). Many other conditions were trialed in "King Chulalongkorn Memorial Hospital" in a lesser frequency.

Most popular intervention types in "King Chulalongkorn Memorial Hospital" are "Drug" (85 trials), "Other" (19 trials), "Device" (16 trials), "Procedure" (11 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Rituximab" (4 trials), "Bortezomib" (2 trials), "Dexamethasone" (2 trials) and "EPIAO®" (2 trials). Other intervention names were less common.

The vast majority of trials in "King Chulalongkorn Memorial Hospital" are 124 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 33 active trials in "King Chulalongkorn Memorial Hospital". 1 are not yet recruiting, 20 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in King Chulalongkorn Memorial Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in King Chulalongkorn Memorial Hospital, 15 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 28 trials that are defined as “Not Applicable".

King Chulalongkorn Memorial Hospital has several departments that took part in Clinical trials: "Chulalongkorn Hospital; Medical Oncology" - 25 trials, "King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine" - 5 trials, "King Chulalongkorn Memorial Hospital; Ophthalmology Department" - 3 trials, "Department of Surgery, King Chulalongkorn Memorial Hospital" - 3 trials, "Division of Dermatology, Faculty of Medicine, Chulalongkorn University" - 3 trials, "Gastroenterology Unit, King Chulalongkorn Memorial Hospital" - 2 trials, "Thai Red Cross Emerging Infectious Diseases (EDI) Clinic" - 2 trials, "Emergency Medicine Unit, King Chulalongkorn Memorial Hospital" - 2 trials